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Abstract
Introduction: Age-related macular degeneration is a serious visual disorder of the central retina and was recently
reported to be associated with genetic background. Here we describe a genetic link to early onset age-related
macular degeneration in members of an Asian family.
Case presentation: A 73-year-old Asian woman developed age-related macular degeneration in the fifth decade of
her life and her 49-year-old daughter developed age-related macular degeneration. Because of the family history
and the early onset, family members were tested for two single nucleotide polymorphism variants (rs10490924 and
rs11200638) at a recently identified susceptibility locus for age-related macular degeneration. Both alleles in the
73-year-old woman were of the high-risk variants (T/T for rs10490924 and A/A for rs11200638), and her two
daughters and a grandson each carried the risk variants (T and A) one on each allele.
Conclusions: In a case where multiple family members had early onset age-related macular degeneration, we
found two high-risk single nucleotide polymorphism variants in the age-related macular degeneration susceptibility
locus, suggesting the combination of the known single nucleotide polymorphism variants as a potent age-related
macular degeneration diagnostic indicator.
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Introduction
Age-related macular degeneration (AMD) is a serious
visual disorder of the central retina and it is prevalent
in developed countries [1, 2]. In Asian patients, ex-
udative (wet) AMD occurs more frequently than geo-
graphic atrophy (dry) AMD seen in European patients
with late AMD [3, 4]. Choroidal vasculopathy around
the macula triggers abnormal neovascularization, lead-
ing to serious hemorrhaging and exudation [5]. For
most European patients, without such hemorrhages,
retinal thinning is accompanied by atrophy of the ret-
inal pigment epithelium [5].
Irrespective of similarities in phenotypic defects
among AMD types, the mechanisms underlying the de-
velopment of AMD are not well understood. However,
from the familial incidence of AMD, genetic background
has been suspected and, accordingly, genes associated
with AMD have been identified for both the dry and wet
types of AMD [6–8]. Recent genetic association studies
have been successful in identifying several AMD risk-
associated single nucleotide polymorphism (SNP) vari-
ants, and the SNP variants are specific to AMD type,
reflecting different genetic backgrounds among races.
Through genome-wide association studies (GWASs) on
large populations of patients with AMD that included
independent groups, several SNP susceptibility variants
were identified in genes encoding complement factor H
(CFH), high-temperature requirement factor A1
(HTRA1) and age-related maculopathy susceptibility 2
(ARMS2), as well as in the regions for TNFSF10A-
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LOC389641 and REST-C4orf14-POLR2B-IGFBP7 for
dry-type [9] and for wet-type AMD [10, 11].
Diagnosis of AMD is certified for patients over 50
years of age, but there is also a group of patients with
AMD with early onset [1, 2]. For such patients, heredi-
tary SNP variation in loci associated with AMD is as-
sumed. We report here an Asian case of familial AMD
with early onset bearing both of the known high-risk
SNP variants (rs10490924 and rs11200638 in ARMS2
and HTRA1, respectively) [10, 11] in patients with
AMD, suggesting a genetic association between the two
SNPs in AMD onset.
Case presentation
A 73-year-old Asian woman consulted 19 years ago
(1996) requesting examination of her right eye, since
both eyes bore pterygium and her left eye was diagnosed
as having wet-type AMD in another ophthalmological
clinic 23 years ago (1992); she is designated as Patient A
(PA) in the rest of this case report. She was reported to
have blurriness in her central visual field in the early
part of the third decade of her life. Intraocular pressure
was 14 mmHg in her right eye and 12 mmHg in her left
eye, and no overt abnormalities were seen in the cornea
or the crystalline lens in either eye by slit lamp test in
1996. A fluorescein angiogram (FAG) in 1996 and a fun-
dus examination in 2007 of her right eye showed clas-
sical wet-type AMD with choroidal neovascularization,
hyperpigmentation and reticular pseudodrusen (Fig. 1).
Her best-corrected visual acuity was 20/25 for her right
eye and 20/30 for her left eye in 1992, but these acuities
gradually decreased over several years to 20/300 for
her left eye and, in 2003, they reached less than 20/
400 in both eyes. A SNP survey was conducted last
year for the recently reported susceptibility loci
ARMS2 and HTRA1 for wet AMD (Fig. 2a). Both
SNP variants in this patient (PA) were high-risk al-
leles: T/T for rs10490924 in the coding region (a mu-
tation that converts alanine 69 into serine in the
ARMS2 protein; A69S) and A/A for rs11200638 in
the promoter of the HTRA1 gene (Fig. 2a, b) [10, 11].
After these findings from SNP analysis, one of PA’s
daughters, who was 49 years of age (Patient B; PB),
visited our hospital for a SNP survey; she also mani-
fested blurred central vision in her left eye and was
afraid of AMD. Her best-corrected visual acuity was
20/20 for her right eye and 20/25 for her left eye. In-
traocular pressure was 16 mmHg for her right eye
and 15 mmHg for her left eye; neither eye exhibited
overt abnormalities by slit lamp examination. How-
ever, in a fundus examination, abnormality of the ret-
inal pigment epithelium was detected, as well as
reticular pseudodrusen, and she was diagnosed as
having classic wet AMD in 2014 (Fig. 1). To prevent
AMD progression, an anti-vascular endothelial growth
factor (VEGF) antibody, Eylea (aflibercept ophthal-
mic), for the left eye of PB was administered in 2014.
After 10 months, she reported that blurring was ame-
liorated and the best-corrected visual acuity for her
left eye was consistently found to be 20/20. PB and
her younger sister, at 45 years of age (Patient C; PC),
took the SNP survey (Fig. 2b, c). High-risk variants
were found in both high-risk loci: T for rs10490924
and A for rs11200638 [11, 12]. The younger sister
Fig. 1 Color fundus photographs and fluorescein angiograms. a Fundus photographs of the patients (PA and PB are the family members
depicted in Fig. 2). The images for PA were taken in 2007 and those for PB in 2014. b Fluorescein angiograms for PA taken in 1996 and PB in
2014. Choroidal neovascularization, hyperpigmentation and reticular pseudodrusen were seen as representative markers for classical wet type of
age-related macular degeneration. PA Patient A, PB Patient B
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(PC) and the grandson (Patient D; PD) had no mani-
festations of any AMD-related visual defect.
Discussion
AMD is a common eye condition among patients aged
50 years and older [1, 2]. The onset and progression of
AMD are diverse, but AMD, per se, is generally not ser-
ious enough to cause complete blindness [1, 2]. How-
ever, the loss of central vision from damage to the
macula threatens the visual abilities that support every
aspect of normal life, since the center of the field of view
is distorted [1–4].
Although common features are detected among pa-
tients with AMD, the molecular basis of AMD onset
and development remains to be uncovered. Moreover,
effective treatments and drugs to prevent AMD are still
in clinical trials [12, 13]. In this respect, investigation of
genetic variants in patients with AMD in large popula-
tions is a promising strategy for identifying molecular
targets for intervention in AMD, as it is well established
that familial history is a strong predictor of AMD.
Among the AMD susceptibility loci [6–11], we identified
two SNP variants that mutated A69 of the ARMS2 pro-
tein into alanine (A69S) (T/T for rs10490924) and a vari-
ation with high risk (A/A) in the promoter of the
HTRA1 gene at rs11200638, since these SNP variants
are predictive of AMD incidence with high odds ratios
(2.86) by GWAS analyses of large numbers of patients
with AMD [10]. Moreover, a mechanistic link between
the ARMS2 A69S mutation and AMD progression has
been illustrated [10]. Both of the tested high-risk alleles
(T for rs10490924 and A for rs11200638) were found in
all of the Asian family members, and all of them had
had dry eye since adolescence. As the relationship
among the multiple susceptibility gene loci delineated by
several independent groups remains to be studied in
terms of development and onset of AMD, our findings
are intriguing because they suggest mutual associations
among the identified susceptibility gene loci. Further as-
sessment of other SNP variants related to AMD may
Fig. 2 Single nucleotide polymorphism variant analysis of a family with age-related macular degeneration in the age-related macular degener-
ation susceptibility locus around the ARMS2 and HTRA1 genes. a Two loci for single nucleotide polymorphism variants (rs10490924 and
rs11200638) in the ARMS2 and HTRA1 genes on chromosome 10q26. b Sequence electropherograms of the rs10490924 and rs11200638 loci for
each of the family members. c Pedigree of the family with genetic variants in rs10490924 and rs11200638 loci on chromosome 10q26. PA Patient
A, PB Patient B, PC Patient C, PD Patient D
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add more genetic information. This study has many lim-
itations because it is a case report and needs more
examination to assess our conclusions. It is also evident
that other factors underlie the onset and development of
AMD. However, the present case study represents a ra-
tional approach to provide a prevention strategy for
those at risk for AMD, particularly for those with a fa-
milial AMD history.
Conclusions
An Asian family with early onset AMD bore the known
high-risk SNP variants in both ARMS2 and HTRA1; the
presence of both SNPs could be an indicator for early
onset AMD.
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